•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A08075 Summary:

BILL NOA08075D
 
SAME ASSAME AS S08991-A
 
SPONSORSteck
 
COSPNSRFahy, Gunther, McDonald, Novakhov, DeStefano, Simon, Davila, Bendett, Brown K, Chang, Levenberg, Weprin, Solages, Paulin
 
MLTSPNSRWoerner
 
Amd §19.09, Ment Hyg L; amd §3309, Pub Health L
 
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.
Go to top    

A08075 Actions:

BILL NOA08075D
 
09/27/2023referred to alcoholism and drug abuse
10/11/2023amend and recommit to alcoholism and drug abuse
10/11/2023print number 8075a
10/27/2023amend and recommit to alcoholism and drug abuse
10/27/2023print number 8075b
01/03/2024referred to alcoholism and drug abuse
01/30/2024amend (t) and recommit to alcoholism and drug abuse
01/30/2024print number 8075c
04/09/2024reported referred to ways and means
06/03/2024amend and recommit to ways and means
06/03/2024print number 8075d
06/05/2024reported referred to rules
06/05/2024reported
06/05/2024rules report cal.448
06/05/2024ordered to third reading rules cal.448
06/07/2024passed assembly
06/07/2024delivered to senate
06/07/2024REFERRED TO RULES
Go to top